Create a narrative

Amneal Pharmaceuticals Community

NasdaqGS:AMRX Community

1 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Create a narrative

Amneal Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

CREXONT And Metsera Partnerships Will Capitalize On Growing GLP-1 Market

Key Takeaways The strategic collaboration in GLP-1 therapies and biosimilars expands market reach, poised to drive significant future revenue growth. Strong performance in injectables and AvKARE segments underpins diversified revenue and enhances top-line growth and profitability.

US$11.67

FV

36.5% undervalued

7.42%

Revenue growth p.a.

0

0

4

11 days ago